Cargando…
Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?
BACKGROUND: Severe inflammation and one or more extrapulmonary organ dysfunctions have been reported and this clinical picture is defined as "multisystem inflammatory syndrome in adults" (MIS-A) in severe coronavirus disease-2019 (COVID-19). We aimed to determine the effect of LDH/lymphocy...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960085/ https://www.ncbi.nlm.nih.gov/pubmed/35346086 http://dx.doi.org/10.1186/s12879-022-07303-8 |
_version_ | 1784677311408242688 |
---|---|
author | Serin, Istemi Sari, Nagehan Didem Gunaltili, Murat Karakilic, Ayse Gulesir, Begum Kal Kolik, Beyza Cevik, Gulnihal Sungurlu, Hilal Keskin, Melike Baltik, Muhammed Cakmak, Onurhan Cinli, Tahir Alper |
author_facet | Serin, Istemi Sari, Nagehan Didem Gunaltili, Murat Karakilic, Ayse Gulesir, Begum Kal Kolik, Beyza Cevik, Gulnihal Sungurlu, Hilal Keskin, Melike Baltik, Muhammed Cakmak, Onurhan Cinli, Tahir Alper |
author_sort | Serin, Istemi |
collection | PubMed |
description | BACKGROUND: Severe inflammation and one or more extrapulmonary organ dysfunctions have been reported and this clinical picture is defined as "multisystem inflammatory syndrome in adults" (MIS-A) in severe coronavirus disease-2019 (COVID-19). We aimed to determine the effect of LDH/lymphocyte ratio (LLR) on the development of MIS-A. METHODS: The data of 2333 patients were retrospectively analyzed. RESULTS: MIS-A rate was found to be 9.9% and MIS-A related mortality was 35.3%. LRR level above 0.24 was found to predict MIS-A development with 70% sensitivity and 65.2% specificity. The risk of MIS-A development was found to be 3.64 times higher in those with LRR levels above 0.24 compared to those with 0.24 and below. In patients with MIS-A, LRR level above 0.32 predicts mortality with 78% sensitivity and 70% specificity. CONCLUSIONS: Early detection of MIS-A with high sensitivity and specificity in a practical ratio is very important in terms new studies. |
format | Online Article Text |
id | pubmed-8960085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89600852022-03-29 Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? Serin, Istemi Sari, Nagehan Didem Gunaltili, Murat Karakilic, Ayse Gulesir, Begum Kal Kolik, Beyza Cevik, Gulnihal Sungurlu, Hilal Keskin, Melike Baltik, Muhammed Cakmak, Onurhan Cinli, Tahir Alper BMC Infect Dis Research BACKGROUND: Severe inflammation and one or more extrapulmonary organ dysfunctions have been reported and this clinical picture is defined as "multisystem inflammatory syndrome in adults" (MIS-A) in severe coronavirus disease-2019 (COVID-19). We aimed to determine the effect of LDH/lymphocyte ratio (LLR) on the development of MIS-A. METHODS: The data of 2333 patients were retrospectively analyzed. RESULTS: MIS-A rate was found to be 9.9% and MIS-A related mortality was 35.3%. LRR level above 0.24 was found to predict MIS-A development with 70% sensitivity and 65.2% specificity. The risk of MIS-A development was found to be 3.64 times higher in those with LRR levels above 0.24 compared to those with 0.24 and below. In patients with MIS-A, LRR level above 0.32 predicts mortality with 78% sensitivity and 70% specificity. CONCLUSIONS: Early detection of MIS-A with high sensitivity and specificity in a practical ratio is very important in terms new studies. BioMed Central 2022-03-28 /pmc/articles/PMC8960085/ /pubmed/35346086 http://dx.doi.org/10.1186/s12879-022-07303-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Serin, Istemi Sari, Nagehan Didem Gunaltili, Murat Karakilic, Ayse Gulesir, Begum Kal Kolik, Beyza Cevik, Gulnihal Sungurlu, Hilal Keskin, Melike Baltik, Muhammed Cakmak, Onurhan Cinli, Tahir Alper Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? |
title | Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? |
title_full | Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? |
title_fullStr | Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? |
title_full_unstemmed | Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? |
title_short | Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? |
title_sort | enigma of covid-19: is “multisystem inflammatory syndrome in adults” (mis-a) predictable? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960085/ https://www.ncbi.nlm.nih.gov/pubmed/35346086 http://dx.doi.org/10.1186/s12879-022-07303-8 |
work_keys_str_mv | AT serinistemi enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT sarinagehandidem enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT gunaltilimurat enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT karakilicayse enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT gulesirbegum enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT kalkolikbeyza enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT cevikgulnihal enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT sungurluhilal enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT keskinmelike enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT baltikmuhammed enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT cakmakonurhan enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable AT cinlitahiralper enigmaofcovid19ismultisysteminflammatorysyndromeinadultsmisapredictable |